EMFAT
TEVA icon

Emerald Mutual Fund Advisers Trust’s Teva Pharmaceuticals TEVA Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,646
Closed -$192K – 239
2024
Q3 		$192K Hold
10,646
– – 0.01% 193
2024
Q2 		$173K Sell
10,646
-298
-3% -$4.59K 0.01% 194
2024
Q1 		$154K Buy
+10,944
New +$138K 0.01% 201

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's TEVA Position: Q4 2024 in Review

Emerald Mutual Fund Advisers Trust sold out of Teva Pharmaceuticals (TEVA) in Q4 2024, closing a stake of 10,646 shares — an estimated $192K sold.

Emerald Mutual Fund Advisers Trust first reported a position in TEVA in Q1 2024 and held it in 3 quarters. The position peaked at $192K in Q3 2024. 583 funds tracked by Wall St. Rank hold TEVA as of Q4 2024.

  • Emerald Mutual Fund Advisers Trust reported no remaining Teva Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 10,646 Teva Pharmaceuticals shares in Q4 2024, an estimated $192K.
  • Emerald Mutual Fund Advisers Trust first reported a position in Teva Pharmaceuticals in Q1 2024 and held it in 3 quarters.
  • Emerald Mutual Fund Advisers Trust's Teva Pharmaceuticals position peaked at $192K in Q3 2024.
  • 583 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2024.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2024, filed 14 Feb 2025.